Pharming Group N.V. (AMS:PHARM)

Netherlands · Delayed Price · Currency is EUR

1.102

-0.009 (-0.77%)

Jul 24, 2026, 5:35 PM CET

Pharming Group Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	369.49	376.13	297.2	245.32	205.62	198.87
Revenue Growth	15.21%	26.56%	21.15%	19.30%	3.40%	-6.27%
Gross Profit	325.67	330.63	261.8	220.1	188.06	177.73
Operating Income	34.89	32.76	-3.59	-21.75	10.37	24
Net Income	12.36	2.85	-11.84	-10.55	13.67	16
Earnings Per Share	0.02	0.00	-0.02	-0.02	0.02	0.02
EPS Growth	-	-	-	-	-17.39%	-58.18%

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Ruconest®	307.72	317.92	252.24	227.13	205.62
Joenja®	61.81	58.21	44.96	18.18	-
Total	369.53	376.13	297.2	245.32	205.62

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	170.18	179.1	167.89	213.42	207.34	191.92
Total Debt	116.21	115.78	112.31	171.55	166.69	161.76
Net Cash (Debt)	53.97	63.33	55.58	41.88	40.65	30.16
Net Cash Growth	-	13.94%	32.72%	3.03%	34.76%	-30.18%
Net Cash Per Share	0.07	0.08	0.08	0.06	0.06	0.04

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	56.43	54.71	-1.8	-17.3	22.46	37.84
Capital Expenditures	-0.71	-0.75	-0.79	-1.44	-1.38	-10.74
Free Cash Flow	55.72	53.96	-2.59	-18.74	21.08	27.1
Free Cash Flow Growth	994.32%	-	-	-	-22.21%	-65.68%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	88.14%	87.90%	88.09%	89.72%	91.46%	89.37%
Operating Margin	9.44%	8.71%	-1.21%	-8.87%	5.04%	12.07%
Pretax Margin	5.38%	3.42%	-2.86%	-4.90%	7.29%	11.60%
Profit Margin	3.34%	0.76%	-3.98%	-4.30%	6.65%	8.04%
FCF Margin	15.08%	14.35%	-0.87%	-7.64%	10.25%	13.63%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	77.88	402.37	-	-	55.27	35.75
Forward PE	41.68	56.32	56.32	153.88	27.10	14.49
P/FCF Ratio	16.10	21.26	-	-	35.85	21.10
PS Ratio	2.43	3.05	2.19	3.11	3.68	2.88